If you're running a clinical trial, you know the data is everything. But raw data doesn't get you FDA approval—rigorous, defensible analysis does. That's why choosing the right biostatistics consulting partner is one of the most critical decisions you'll make.
Why Biostatistics Consulting Matters More Than Ever
The clinical trial landscape is getting more complex. With the rise of real-world evidence (RWE), adaptive trial designs, and personalized medicine, the statistical demands on sponsors have never been higher. Regulators like the FDA expect robust, pre-specified analysis plans and transparent reporting. A misstep in sample size calculation or endpoint selection can cost millions and delay your drug's path to market. That's why specialized biostatistics consulting firms have become indispensable partners. They bring deep expertise in everything from Phase I dose-finding to Phase III confirmatory trials, helping you navigate regulatory hurdles and make data-driven decisions with confidence.
How I Ranked These Firms
To build this list, I evaluated each firm on five key criteria: depth of therapeutic expertise (can they handle your specific disease area?), regulatory track record (have they successfully navigated FDA submissions?), range of services (do they offer study design, analysis, and reporting?), client focus (do they work with small biotechs or only big pharma?), and communication skills (can they explain complex stats to non-technical stakeholders?). I also considered their experience with modern methodologies like RWE and adaptive designs.
Here's a quick snapshot of the top five biostatistics consulting firms, so you can see at a glance who might be the best fit for your next clinical trial.
| Provider | Best For |
|---|---|
| Allucent | Small to mid-sized biotech companies needing full-service support |
| BSC | Medical device and pharma companies seeking FDA-ready statistical rigor |
| EvoClinical | Sponsors wanting strategic guidance plus AI and RWE integration |
| Dr. David A. Lombardi, Ph.D. - Professional Portfolio | Boutique, personalized consulting from a seasoned biostatistician |
| Linical | Global, full-service clinical trials requiring integrated biostatistics |
The Top 5 Biostatistics Consulting Firms for Clinical Trials
#1 Allucent
A screenshot of the Allucent website.
Allucent is a powerhouse for small and mid-sized biotech companies, offering end-to-end drug development services with a strong biostatistics arm. Their team provides biostatistical consulting that covers everything from study design to regulatory submissions, and they have deep expertise in oncology, infectious disease, and neuroscience. What sets them apart is their focus on the unique challenges of smaller sponsors, helping you navigate complex regulatory pathways without the overhead of a large CRO. They also offer modeling and simulation services to optimize your trial design before you enroll a single patient. If you need a partner that understands the biotech grind, Allucent is a top choice.
#2 BSC
A screenshot of the BSC website.
BSC (Biomedical Statistical Consulting) is a veteran in the space, with decades of FDA-facing biostatistical leadership under their belt. They specialize in medical device and pharmaceutical trials, delivering what they call 'approval-grade' biostatistics that stands up to regulatory scrutiny. Their team focuses on defensible analyses and clear communication, which is critical when you're preparing for an FDA panel. BSC supports sponsors across the full clinical development lifecycle, from early strategy through approval-ready submissions. If your priority is regulatory confidence and a proven track record, BSC is a solid bet.
#3 EvoClinical
A screenshot of the EvoClinical website.
EvoClinical positions itself as a strategic partner, not just a statistical vendor. They offer a broad range of services including biostatistics consulting, clinical study design, AI advisory for life sciences, and even statistical training for your in-house team. Their consultants provide expert input on endpoint selection, sample size justification, and estimand frameworks, which are essential for aligning with regulatory expectations. They also integrate real-world evidence (RWE) and enrollment forecasting into their analyses, giving you a more complete picture of your trial's potential. For sponsors who want a forward-thinking partner that embraces AI and advanced analytics, EvoClinical is a strong contender.
#4 Dr. David A. Lombardi, Ph.D. - Professional Portfolio
A screenshot of the Dr. David A. Lombardi, Ph.D. - Professional Portfolio website.
Dr. David A. Lombardi is an independent biostatistician and epidemiologist with over 30 years of experience spanning pharma, consulting, and academia. He offers personalized, hands-on consulting for clinical trial design and analysis, covering Phase I through III trials and real-world evidence studies. His therapeutic area expertise is remarkably broad, including infectious diseases (HIV-1, COVID-19), oncology (lung cancer, multiple myeloma), neurology (Alzheimer's, Rett syndrome), and regenerative medicine. Dr. Lombardi also excels at explaining complex statistical findings to non-technical audiences, which is invaluable when you need to present to investors or regulators. For a boutique, high-touch experience with a seasoned expert, he's an excellent choice.
#5 Linical
A screenshot of the Linical website.
Linical is a global CRO with a dedicated biostatistics practice that supports trials across multiple therapeutic areas, including oncology, neurology, and immunology. Their biostatisticians are involved from protocol development through final analysis, ensuring consistency and quality throughout the study lifecycle. They also offer biometrics services that integrate biostatistics with data management and statistical programming, streamlining your workflow. Linical's global reach means they can handle multi-site international trials, and they have experience with both early-phase and late-phase studies. If you need a full-service CRO with robust biostatistics capabilities, Linical is a reliable option.
How to Choose the Right Biostatistics Consultant for Your Trial
Start by defining your trial's specific needs. Are you a small biotech needing hands-on guidance from study design through submission? A firm like Allucent or Dr. David A. Lombardi might be ideal. If regulatory rigor is your top concern, especially for medical devices, BSC's FDA-focused approach is hard to beat. For sponsors who want cutting-edge analytics like AI and RWE integration, EvoClinical offers a forward-looking toolkit. And if you need a global CRO that can manage every aspect of your trial, Linical provides comprehensive support. Always ask about their experience in your specific therapeutic area and request references from similar-sized sponsors.
Streamlining Your Trial with Automated Workflows
You can integrate biostatistics consulting into your clinical trial workflow by first using a consultant to finalize your study design and statistical analysis plan (SAP). Then, leverage automated SAS programming (like Dr. Lombardi's expertise with PROC MIXED and PHREG) to run interim analyses and generate tables, listings, and figures (TLFs). Finally, have your consultant review the outputs and prepare the clinical study report (CSR) for regulatory submission, ensuring every step is documented and defensible.
Your Next Step Toward Trial Success
Choosing the right biostatistics partner can make or break your clinical trial. Whether you opt for the full-service support of Allucent, the regulatory focus of BSC, the innovative analytics of EvoClinical, the personalized touch of Dr. David A. Lombardi, or the global reach of Linical, the key is to align their strengths with your trial's unique challenges. Don't wait until you're knee-deep in data—engage a consultant early to design a study that's built for success from day one.